Drug treatment in dementia
- 1 July 2001
- journal article
- Published by Wolters Kluwer Health in Current Opinion in Psychiatry
- Vol. 14 (4) , 349-353
- https://doi.org/10.1097/00001504-200107000-00019
Abstract
No abstract availableThis publication has 53 references indexed in Scilit:
- Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trialBMJ, 2000
- Weighing the Benefits of New Alzheimer's TreatmentsScience, 2000
- β-Peptide ImmunizationArchives of Neurology, 2000
- A 5-month, randomized, placebo-controlled trial of galantamine in ADNeurology, 2000
- Galantamine in ADNeurology, 2000
- Effectiveness of rivastigmine in Alzheimer's diseaseBMJ, 2000
- Extended-Release Physostigmine in Alzheimer DiseaseArchives of General Psychiatry, 2000
- Donepezil Therapy in Clinical PracticeArchives of Neurology, 2000
- A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's diseaseNeurology, 1998
- A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's DiseaseNew England Journal of Medicine, 1997